PB1909 low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation

Absztrakt
Leírás
Kulcsszavak
Forrás
HemaSphere. -7 : S3 (2023), p. 3677-3678. -Hemasphere. - 2572-9241